Table 1 Summary of the control and treatment groups used in the study
From: Lithium as a disease-modifying agent for prion diseases
Treatment | Number of mice | Route | Lithium dose (µg/kg/day) |
---|---|---|---|
Vehicle (control) | 13 | Rectal | 0 |
NP03-lithium | 14 | Rectal | 40 |
NP03-lithium | 14 | Rectal | 160 |
Lithium solution | 14 | Oral | 16,000 |